Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant Therapy
Jeffrey Liles(Loyola University Chicago), Jawed Fareed(Loyola University Chicago), Christopher Wanderling(University of Rochester), Debra Hoppensteadt(Brigham and Women's Hospital), Mushabbar Syed(Loyola University Medical Center), Jordan Liles(Steadman Clinic)
Cited by 19
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
|JAMA|2019|370
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*
|Critical Care Medicine|2013|322
Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study
|Investigative Ophthalmology & Visual Science|2015|38
Recent Advances in Surgical Simulation For Resident Education
|Current Urology Reports|2023|30